YAMILETH WU-GERRARD: Open Payments
NPI 1215977707 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 10 payments from 8 companies in 2025. Trend: 2023 $419 · 2024 $361 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 2 | $236 |
| Fresenius USA Marketing, Inc. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 1 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $35 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Ardelyx, Inc. | 1 | $28 |
| AKEBIA THERAPEUTICS INC | 1 | $22 |
Products named: Veltassa, VELPHORO, PURIFIED CORTROPHIN GEL, TARPEYO, JYNARQUE, IBSRELA, Vafseo.
Industry payments across DE — which companies pay providers there.
